optimizing treatment of alk nsclc: clinical realities
Published 6 years ago • 44 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
2:10
molecularly-guided treatment of advanced nsclc: alk inhibitor sequencing
-
2:07
clinical updates on alk inhibitor treatment strategies for nsclc
-
0:58
progress in the treatment of alk-positive non-small cell lung cancer
-
3:53
how to maximize clinical benefits for patients with alk-positive non-small cell lung cancer
-
1:13
brain metastases and lung cancer: optimizing treatment using biomarkers
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
15:25
targeted therapies: the future of non-small cell lung cancer (nsclc) treatment?
-
3:04
management of frontline alk nsclc: brigatinib vs. alectinib
-
1:24
optimizing neoadjuvant therapy in nsclc with biomarker research
-
1:20:16
optimizing advanced nsclc biomarker testing, treatment and management session 1
-
1:42
next-generation alk inhibitors: treatment sequencing and resistance
-
1:41
recent developments in the treatment of nsclc
-
10:43
updates in alk nsclc
-
41:11
optimizing treatment selection, sequencing, and tolerability in small cell lung cancer
-
1:23
i-o monotherapy for advanced nsclc
-
4:28
changing the treatment paradigm for alk-rearranged nsclc
-
2:47
etop clinical trials in egfr-, krasg12c- and alk-mutated nsclc
-
6:51
progression in alk nsclc after frontline therapy